Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_provenance.
- NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_assertion description "[ Combined pharmacogenetic testing for CYP2D6 and CYP2C19 identifies patients with low risk for side effects in amitriptyline therapy and could possibly be used to individualize antidepressive regimens and reduce treatment cost. Identification of genotypes]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_provenance.
- NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_assertion evidence source_evidence_literature NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_provenance.
- NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_assertion SIO_000772 15590749 NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_provenance.
- NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_assertion wasDerivedFrom gad-20150221 NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_provenance.
- NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_assertion wasGeneratedBy ECO_0000203 NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_provenance.
- gad-20150221 importedOn "2015-02-21" NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_provenance.